Sign up to save your podcasts
Or
Share The Role of Implementation Science in Familial Hypercholesterolemia
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Role of Implementation Science in Familial Hypercholesterolemia
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Laney K. Jones, PharmD, MPH
Patients with familial hypercholesterolemia (FH) are at an increased risk of developing coronary heart disease at a young age. So what’s on the horizon for using implementation science strategies in treating patients with FH? Learn more about implementation science as Dr. Mary Katherine Cheeley discusses this with Dr. Laney Jones, Associate Professor at Geisinger’s Department of Genomic Health.
View all episodes
By ReachMDHost: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Laney K. Jones, PharmD, MPH
Patients with familial hypercholesterolemia (FH) are at an increased risk of developing coronary heart disease at a young age. So what’s on the horizon for using implementation science strategies in treating patients with FH? Learn more about implementation science as Dr. Mary Katherine Cheeley discusses this with Dr. Laney Jones, Associate Professor at Geisinger’s Department of Genomic Health.